• Return to Headlines

33.3% Return Seen to Date on SmarTrend Immunogen Call (IMGN)

By Amy Schwartz

SmarTrend identified an Uptrend for Immunogen (NASDAQ:IMGN) on April 20th, 2017 at $3.92. In approximately 4 weeks, Immunogen has returned 33.29% as of today's recent price of $5.23.

In the past 52 weeks, Immunogen share prices have been bracketed by a low of $1.51 and a high of $20.25 and are now at $5.22, 246% above that low price. In the last five trading sessions, the 50-day moving average (MA) has fallen 1.2% while the 200-day MA has slid 2.2%.

ImmunoGen, Inc. develops pharmaceuticals, primarily for the treatment of cancer. The Company's tumor activated prodructs deliver chemotherapy specifically to a tumor. ImmunoGen has three drugs in clinical trials and is negotiating to take a drug into phase II trial. These products are being tested for the treatment of colorectal and small-cell lung cancer.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Immunogen shares.

Log in and add Immunogen (IMGN) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights immunogen

Ticker(s): IMGN